Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03654716 |
|---|---|
| Brief Title: | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer |
| First Submitted : | August 29, 2018 |
| First Submitted that Met QC Criteria : | August 29, 2018 |
| First Posted : | August 31, 2018 |
| Last Update Submitted that Met QC Criteria : | August 10, 2023 |
| Last Update Posted : | August 14, 2023 |